Effectiveness and safety of fingolimod in patients with multiple sclerosis switched from natalizumab: Results from TRANSITION, a 2 year observational study

Authors

• Helmut Butzkueven
• Paul S. Giacomini
• Stanley Cohan, Providence Multiple Sclerosis Center, USA.Follow
• Tjalf Ziemssen
• B Weller

Document Type

Article

Publication Date

2017

Keywords

oregon; providence neuroscience institute

Area of Special Interest

Neurosciences (Brain & Spine)

Specialty/Research Institute

Neurosciences